Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. - Wikidata - awgldk - TriplyDB

Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.

Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.

http://www.wikidata.org/entity/Q33549622

about

Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR Images Emerging methods for disease monitoring in malignant gliomas Recent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma Patients Diffusion and perfusion weighted magnetic resonance imaging for tumor volume definition in radiotherapy of brain tumors Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy MR Imaging Biomarkers in Oncology Clinical Trials Perfusion MRI: the five most frequently asked clinical questions.Functional imaging in adult and paediatric brain tumours.Pseudoprogression in high-grade glioma.Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.Principles of T2 *-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging.Advanced magnetic resonance imaging of the physical processes in human glioblastoma.Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain.Advanced MR Imaging in Neuro-oncology.Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma.[Pseudoprogression or pseudoresponse: a challenge for the diagnostic imaging in Glioblastoma multiforme].Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma.Pseudoprogression: relevance with respect to treatment of high-grade gliomas.Neuroradiological response criteria for high-grade gliomas.Central nervous system cancers Survival analysis of patients with high-grade gliomas based on data mining of imaging variables.Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how?sfDM: Open-Source Software for Temporal Analysis and Visualization of Brain Tumor Diffusion MR Using Serial Functional Diffusion Mapping.Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment.Parametric response maps of perfusion MRI may identify recurrent glioblastomas responsive to bevacizumab and irinotecan.Evaluation of early imaging response criteria in glioblastoma multiforme.In vivo magnetic resonance imaging of sodium and diffusion in rat glioma at 21.1 T.A preliminary quantitative proteomic analysis of glioblastoma pseudoprogression Post-treatment imaging of high-grade gliomas Integrated multimodal imaging of dynamic bone-tumor alterations associated with metastatic prostate cancer.Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.Parametric response mapping of CT images provides early detection of local bone loss in a rat model of osteoporosis.Development of a Multiparametric Voxel-Based Magnetic Resonance Imaging Biomarker for Early Cancer Therapeutic Response Assessment.MR-guided radiation therapy: transformative technology and its role in the central nervous system.Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis.Diffusion MR Characteristics Following Concurrent Radiochemotherapy Predicts Progression-Free and Overall Survival in Newly Diagnosed Glioblastoma MRI perfusion in determining pseudoprogression in patients with glioblastoma.The promise of dynamic contrast-enhanced imaging in radiation therapy Serial MR diffusion to predict treatment response in high-grade pediatric brain tumors: a comparison of regional and voxel-based diffusion change metrics

P2860

Q26743358-F1CB5075-F88F-4D87-9BB4-B3DCEF4D1F9E Q27023823-42B64B65-7C08-430E-9A32-037273FED78E Q28066044-34C08328-597F-4C92-A5E1-885A31093225 Q28067114-CB55D52F-06BA-4B49-90B9-25574F9B9779 Q28279046-8D00767A-23A8-41EF-AE45-58C63E1824A1 Q30364608-8BBAD441-D04E-4E29-93C5-FC8546CB0D8E Q30416198-FA88D212-9140-47FF-A4E4-E4CF27ABCD11 Q30577397-E3D97439-D6D5-4B48-BF13-BA8B896253CD Q30578798-0516F762-94CE-4B32-B385-B90DE75F4222 Q30653828-C63EAB87-B2EC-42A5-92FC-EBEDC2552EDD Q30818733-2AAEE752-A541-4A5C-BC4B-854B7AEE93AD Q30847284-40404C00-AF06-4D28-A883-32F48C4B34B2 Q30907831-D571D786-07D8-4129-9477-A4EF8C3059D0 Q30938805-4958F06B-EB85-4E4A-8A0E-63E95DD68B9C Q30983681-0E7F8DD3-F19D-4C5F-BE8F-38DB4CA36C95 Q33698886-F7FBA4C1-A635-4984-B311-A831E879FDD5 Q33818313-F4FE07F7-667E-4CE0-9AE1-A5B869A86FD2 Q33843085-86636E06-9130-42E1-85C5-17F9CF9BDF3E Q33905441-F507F7C8-A588-4B4F-B712-10C1CEC6EBCA Q33935125-F532C851-D7C5-4812-A637-92A83962C55B Q34014740-57A015DA-1C0F-4151-9287-9DB02DD4A08A Q34155776-411BDBC6-6E4A-4D31-8AEB-C63892034522 Q34256394-B7BD0837-1892-427C-AA54-A43319E69EBA Q35042226-19E7F794-C968-41B9-906B-00DB1B287B1F Q35115962-19524892-FD89-42A1-AEF9-C213B39373DB Q35133246-5FE3A498-8CDC-421A-A573-40314B1CA1E2 Q35289895-67E8EC94-4C66-43F3-A864-4DCABAF568AD Q35353492-B48B185A-F8C4-40B0-9EA7-77BE2A4B3B2C Q35368468-DABAA291-FD7D-46ED-AB1E-C48423642236 Q35568711-C8A14194-73F7-4F48-B64E-5F18AF008533 Q35598954-9E5F13FB-7DE2-4CFD-A20F-FDB7E610D8B7 Q35771783-EC4C92F1-FBC6-4D7D-8DA8-3275CAD4C518 Q36019924-3DD1E258-7273-4CD8-8E37-4481645D41B2 Q36275542-0775D8DC-DC97-4A4F-B702-83A0172342A1 Q36336361-BA9AF6DC-49B8-40C7-B7FD-3A148650AEDB Q36361484-06735935-DE1D-4E0C-8957-D285476CBAC7 Q36424068-A79007FB-3B2A-4208-B8C1-D1B7E80BFF3C Q36585386-BDADD8B4-07AA-4346-AF99-BA37233B61AA Q36747134-4D4C00AD-F327-4570-BB08-5DBA0023ED9E Q37021537-D31758AF-83C0-436A-BB0E-5A51F1044DFB

P2860

Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.

http://www.wikidata.org/entity/Q33549622

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Parametric response map as an ...... gression in high-grade glioma.

@ast

Parametric response map as an ...... gression in high-grade glioma.

@en

Parametric response map as an ...... gression in high-grade glioma.

@nl

type

label

Parametric response map as an ...... gression in high-grade glioma.

@ast

Parametric response map as an ...... gression in high-grade glioma.

@en

Parametric response map as an ...... gression in high-grade glioma.

@nl

prefLabel

Parametric response map as an ...... gression in high-grade glioma.

@ast

Parametric response map as an ...... gression in high-grade glioma.

@en

Parametric response map as an ...... gression in high-grade glioma.

@nl

P1433

Q33549622-B37EDDA9-2F1D-4AE3-9364-50E5F9FF9A43

P1476

Q33549622-41B67EE0-DFE7-40DB-916A-F9E4A033975B

P2093

Q33549622-151A2B98-C215-4E6A-8E42-FCC3AAB5D210

Q33549622-3DD6A526-7F6D-44EA-B35D-2B6142AF3385

Q33549622-4864C642-C4E3-4EC5-8895-DBF0FE3896A3

Q33549622-5C722E49-D754-4C33-B96E-92308108631C

Q33549622-8050F389-C547-47C1-AEDE-1A6EE41EF789

Q33549622-8F10F558-6D15-408C-BE4B-938A63693CF3

Q33549622-9BD9B3C6-2212-4EB8-81E4-617F9455DD37

Q33549622-C1C08E96-A318-4866-80ED-92EE46C58F5F

Q33549622-F80460D9-9652-4381-A090-DF9F47DAD572

P2860

Q33549622-08482BE5-B4F4-423A-8768-EA1573EFA2DB

Q33549622-08AB3A47-2686-4426-9BD1-69AD95CF840F

Q33549622-11C0B9E0-000E-4C74-A3FD-1CB3B74F89A0

Q33549622-292A826C-0266-405A-93BD-A5AB5AF1B152

Q33549622-29E65B79-14BF-4D7F-AC4B-7B75985955C8

Q33549622-2C68FC3A-9829-4801-8E2E-BB2A08E583D6

Q33549622-30B07E0D-B57A-4FD0-91DF-243AF7A86B47

Q33549622-3D3ABA2B-9968-4BA7-9A06-4347BF0B9B16

Q33549622-4FB1A3F9-1F00-4E4D-9521-DB00BB9AED9F

Q33549622-74F48C41-B105-4D3A-9CCA-C8EC1EB4EFEE

P304

Q33549622-7FFE2DE0-9AF3-4E77-B6B4-B05346C46E15

P31

Q33549622-CEE896F0-C3A0-427B-8F59-AF673BFE2A93

P356

Q33549622-3C71DD4C-2DAF-4043-B155-4BFDF7FE3B57

P407

Q33549622-90AF8AEC-34F4-4C95-93FD-2063E620BC83

P433

Q33549622-CFD68F45-EE84-4626-9A99-43C60AEA0BE6

P478

Q33549622-7FD9C1D2-7916-43B6-AB9A-102D434C8AB1

P50

Q33549622-BCABED0D-6200-4C11-93C0-5D5AE282C215

Q33549622-C4107ECF-8837-4A09-821E-6B551421E2D3

P577

Q33549622-4743D712-74BC-4284-ACEE-FE0E0C63EB8A

P698

Q33549622-303A0409-B22D-4EEB-964F-FACB51C1B936

P921

Q33549622-F7D6D299-76E5-46F0-8744-947F0C30AF2C

P932

Q33549622-BB2C5CEB-C7F2-4962-96D8-8190170B48EC

P356

JCO.2009.25.3971

P1433

Journal of Clinical Oncology

P1476

Parametric response map as an ...... gression in high-grade glioma.

@en

P2093

Alnawaz Rehemtulla

http://www.w3.org/2001/XMLSchema#string

Brian D Ross

http://www.w3.org/2001/XMLSchema#string

Charles R Meyer

http://www.w3.org/2001/XMLSchema#string

Christina Tsien

http://www.w3.org/2001/XMLSchema#string

Craig J Galbán

http://www.w3.org/2001/XMLSchema#string

Daniel A Hamstra

http://www.w3.org/2001/XMLSchema#string

Larry Junck

http://www.w3.org/2001/XMLSchema#string

Theodore Lawrence

http://www.w3.org/2001/XMLSchema#string

Timothy D Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.

Physiologic and metabolic magnetic resonance imaging in gliomas.

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.

Response criteria for glioma.

Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations.

Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide.

Pseudoprogression and pseudoresponse: challenges in brain tumor imaging.

Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma.

P304

2293-2299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2009.25.3971

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Pia C. Sundgren

Thomas L Chenevert

P577

2010-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20368564

http://www.w3.org/2001/XMLSchema#string

P921

P932

2860441

http://www.w3.org/2001/XMLSchema#string